Zalicus and Hydra Collaborate to Advance Novel Ion Channel Product Candidates for the Treatment of Pain CAMBRIDGE, Mass. – February 9, 2012 – Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and - The Channel Company - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2012-02-10 21:17:35		Zalicus and Hydra Collaborate to Advance Novel Ion Channel Product Candidates for the Treatment of Pain CAMBRIDGE, Mass. – February 9, 2012 – Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and Add to Reading List Source URL: www.hydrabiosciences.com Download Document from Source Website File Size: 130,19 KB Share Document on Facebook